ECSP11010772A - INFECTION INHIBITOR - Google Patents

INFECTION INHIBITOR

Info

Publication number
ECSP11010772A
ECSP11010772A EC2011010772A ECSP11010772A ECSP11010772A EC SP11010772 A ECSP11010772 A EC SP11010772A EC 2011010772 A EC2011010772 A EC 2011010772A EC SP11010772 A ECSP11010772 A EC SP11010772A EC SP11010772 A ECSP11010772 A EC SP11010772A
Authority
EC
Ecuador
Prior art keywords
protein
relates
white spot
virus
spot syndrome
Prior art date
Application number
EC2011010772A
Other languages
Spanish (es)
Inventor
Justinus Maria Vlak
Original Assignee
Univ Wageningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wageningen filed Critical Univ Wageningen
Publication of ECSP11010772A publication Critical patent/ECSP11010772A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se relaciona con una proteína de virus de Síndrome de Mancha blanca y a un virus de molécula de ácido nucléico de un Síndrome de Mancha Blanca que codifica a dicha proteína. También se relaciona con composiciones que comprenden dicha proteína, su uso en una vacuna, vacunas que comprenden dicha proteína y exámenes diagnósticos para la detección del virus especifico de ADN del Síndrome de Mancha blanca o material antigénico. Finalmente, se relaciona a anticuerpos contra dicha proteína.The present invention relates to a white spot syndrome virus protein and a nucleic acid molecule virus of a white spot syndrome encoding said protein. It also relates to compositions comprising said protein, its use in a vaccine, vaccines comprising said protein and diagnostic tests for the detection of the specific DNA virus of the White Spot Syndrome or antigenic material. Finally, it relates to antibodies against said protein.

EC2011010772A 2008-06-20 2011-01-20 INFECTION INHIBITOR ECSP11010772A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08158717 2008-06-20

Publications (1)

Publication Number Publication Date
ECSP11010772A true ECSP11010772A (en) 2011-04-29

Family

ID=39916296

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011010772A ECSP11010772A (en) 2008-06-20 2011-01-20 INFECTION INHIBITOR

Country Status (5)

Country Link
CN (1) CN102046650A (en)
BR (1) BRPI0913246A2 (en)
EC (1) ECSP11010772A (en)
MX (1) MX2010013681A (en)
WO (1) WO2009153337A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109517037B (en) * 2018-10-31 2022-02-08 青岛科技大学 Polypeptide with white spot syndrome virus inhibition effect and application thereof
CN114088943B (en) * 2021-12-01 2024-03-12 江苏省淡水水产研究所 Gold nanoprobe for detecting procambarus clarkia white spot syndrome virus, and preparation method and application thereof
CN114146071B (en) * 2022-02-08 2023-02-28 西北农林科技大学深圳研究院 Application of paeonol and its derivatives in preventing and treating leukoplakia syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1303942A (en) * 1999-11-24 2001-07-18 国家海洋局第三海洋研究所 Prawn white spot baculovirus genome DNA sequence and cDNA sequence
AU2004271211A1 (en) * 2003-09-09 2005-03-17 Aqua Bounty Technologies, Inc. Compositions and methods for inhibiting White Spot Syndrome Virus (WSSV) infection

Also Published As

Publication number Publication date
WO2009153337A1 (en) 2009-12-23
CN102046650A (en) 2011-05-04
BRPI0913246A2 (en) 2016-01-19
MX2010013681A (en) 2011-04-11

Similar Documents

Publication Publication Date Title
CY1118492T1 (en) NOROVIRUS VACCINE PHARMACEUTICAL FORMS
CY1119284T1 (en) PARTICULAR SUBJECTS WITH VIRUS-PROTEIN SOLUTIONS (VLPs)
CY1121632T1 (en) RV2386C TUBERCULOSIS PROTEIN, ITS COMPOSITIONS AND USES
WO2008039267A3 (en) Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
CR20120042A (en) DIRECTED IMMUNOCATE PLAYERS
CY1118153T1 (en) TREATMENT OF MICROBIAL INFECTIONS
BR112014004860A2 (en) influenza virus antibody compositions
EP3587439A3 (en) Improved quantification of vaccine compositions
AR071220A1 (en) ASTROVIRUS AVIARIO DEPOSITED UNDER THE NUERO CNCM I-3895
EA201071365A1 (en) MONOCLONAL ANTIBODIES WITH THE HOMOPODYPE OF CROSS-NEUTRALIZING PROPERTIES AGAINST THE INFLUENZA VIRUS V1
CL2011003273A1 (en) Recombinant respiratory syncytial virus (vrs) antigen, which comprises a soluble f protein polypeptide with a modification that alters its glycosylation and which in turn comprises an f1 domain and an f2 domain of vrs f protein; immunogenic composition comprising it; nucleic acid that encodes it; vector; host cell; method of producing said vrs antigen; and its use to treat a vrs.
CO6630164A2 (en) Proteins that bind to tnf-a
CO6260103A2 (en) COMPOSITIONS THAT INCLUDE ANTIGENS NEUMOCOCIDOS
AR066395A1 (en) REOVIRUS THAT HAVE MODIFIED SEQUENCES
CR20160355A (en) NEUTRALIZING ANTIBODIES OF HUMAN ATOMEGALOVIRUS AND USE OF THE SAME
EA200870129A1 (en) HUMAN ANTIBODIES AGAINST IL-23, COMPOSITIONS, METHODS AND APPLICATIONS
EA200970533A1 (en) LIQUID COMPOSITIONS OF ANTI-BODIES AGAINST RABIES
CL2008002092A1 (en) Conjugate containing two or more antifusogenic peptides and an anti-cd-4 antibody; Method of production; pharmaceutical composition comprising it; antifusogenic polypeptides and use of the conjugate to treat viral infections.
PE20160528A1 (en) ANTIBODIES
UY33297A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A POLYPEPTIDE THAT UNDERSTANDS AT LEAST A CXXC REASON AND HETEROLOGICAL ANTIGENS AND USES OF THE SAME
CO6210756A2 (en) THE TIMICA CANINA STROMAL LYMPHOPOYETINE PROTEIN AND USES OF THE SAME
BRPI0919236A8 (en) GAS COMBINATION THERAPEUTIC AND VACCINES
BR112014029274A2 (en) isolated antibody, pharmaceutical composition, use of the antibody, method for treating rabies infection, kit for treating rabies infection, kit for detecting rabies virus, isolated nucleic acid, and host cell.
EA201001045A1 (en) MODIFIED FLU VIRUS
CO6440541A2 (en) BOVINE VIRAL DIARREA VIRUS WITH A MODIFIED ERNS PROTEIN